Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ALC Alcon	$87.00 +0.2%	$89.08	$80.48 ▼ $101.10	$42.81B	0.95	1.21 million shs	2.52 million shs
GEHC GE HealthCare Technologies	$75.20 +0.8%	$71.85	$57.65 ▼ $94.80	$34.16B	1.14	3.53 million shs	3.52 million shs
HLN Haleon	$10.04 -1.1%	$10.72	$8.58 ▼ $11.42	$45.60B	0.25	9.58 million shs	12.78 million shs
IDXX IDEXX Laboratories	$538.84 -1.2%	$512.86	$356.14 ▼ $579.02	$43.87B	1.54	647,191 shs	485,932 shs

(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ALC Alcon	-0.98%	-1.69%	-1.26%	+4.64%	-2.95%
GEHC GE HealthCare Technologies	-2.02%	+0.73%	+4.17%	+27.00%	-3.18%
HLN Haleon	-1.88%	-1.93%	-8.22%	+8.72%	+19.95%
IDXX IDEXX Laboratories	-0.14%	+1.72%	+3.93%	+51.11%	+12.26%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ALC Alcon	2.0129 of 5 stars	2.4	3.0	0.8	0.0	1.9	0.8	1.3
GEHC GE HealthCare Technologies	4.1046 of 5 stars	3.4	3.0	1.7	0.0	2.9	1.7	2.5
HLN Haleon	2.9794 of 5 stars	2.4	3.0	2.5	0.0	1.8	0.0	2.5
IDXX IDEXX Laboratories	3.8044 of 5 stars	1.4	4.0	0.0	3.7	3.4	2.5	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ALC Alcon	2.80	Moderate Buy	$106.13	21.98% Upside
GEHC GE HealthCare Technologies	2.83	Moderate Buy	$88.27	17.38% Upside
HLN Haleon	2.73	Moderate Buy	$12.33	22.76% Upside
IDXX IDEXX Laboratories	2.80	Moderate Buy	$558.11	3.58% Upside

Current Analyst Ratings Breakdown

Latest IDXX, HLN, GEHC, and ALC Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/2/2025	IDXX IDEXX Laboratories	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Hold ➝ Hold	$510.00 ➝ $540.00
7/1/2025	IDXX IDEXX Laboratories	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$625.00
6/11/2025	IDXX IDEXX Laboratories	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$515.00 ➝ $580.00
5/27/2025	HLN Haleon	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
5/27/2025	HLN Haleon	BNP Paribas Exane Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Outperform	$13.40
5/22/2025	ALC Alcon	Kepler Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
5/20/2025	ALC Alcon	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold
5/19/2025	IDXX IDEXX Laboratories	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Hold ➝ Hold	$460.00 ➝ $510.00
5/14/2025	ALC Alcon	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy	$102.00 ➝ $99.00
5/14/2025	ALC Alcon	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$110.00 ➝ $110.00
5/9/2025	HLN Haleon	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Equal Weight ➝ Overweight	$11.25

(Data available from 7/8/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ALC Alcon	$9.91B	4.33	$5.57 per share	15.62	$43.70 per share	1.99
GEHC GE HealthCare Technologies	$19.67B	1.75	$5.82 per share	12.91	$18.53 per share	4.06
HLN Haleon	$14.35B	3.14	$0.49 per share	20.36	$4.58 per share	2.19
IDXX IDEXX Laboratories	$3.90B	11.12	$12.28 per share	43.89	$19.48 per share	27.66

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ALC Alcon	$1.02B	$2.25	38.67	26.44	2.22	11.28%	6.95%	4.92%	8/19/2025 (Estimated)
GEHC GE HealthCare Technologies	$1.99B	$4.75	16.22	14.46	2.51	11.02%	24.95%	6.38%	7/30/2025 (Estimated)
HLN Haleon	$1.84B	$0.39	26.03	20.49	2.89	12.86%	17.65%	8.58%	8/7/2025 (Estimated)
IDXX IDEXX Laboratories	$887.87M	$10.82	49.80	39.68	3.98	22.76%	57.35%	26.97%	8/4/2025 (Confirmed)

Latest IDXX, HLN, GEHC, and ALC Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/4/2025	Q2 2025	IDXX IDEXX Laboratories	$3.28	N/A	N/A	N/A	$1.06 billion	N/A
7/30/2025	Q2 2025	GEHC GE HealthCare Technologies	$0.91	N/A	N/A	N/A	$4.96 billion	N/A
5/13/2025	Q1 2025	ALC Alcon	$0.77	$0.73	-$0.04	$0.70	$2.52 billion	$2.33 billion
5/1/2025	Q1 2025	IDXX IDEXX Laboratories	$2.93	$2.96	+$0.03	$2.96	$998.25 million	$998.43 million
4/30/2025	Q1 2025	GEHC GE HealthCare Technologies	$0.91	$1.01	+$0.10	$1.23	$4.66 billion	$4.78 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ALC Alcon	N/A	N/A	N/A	N/A	4 Years
GEHC GE HealthCare Technologies	$0.14	0.19%	N/A	2.95%	1 Years
HLN Haleon	$0.25	2.49%	N/A	64.10%	N/A
IDXX IDEXX Laboratories	N/A	N/A	N/A	N/A	N/A

Latest IDXX, HLN, GEHC, and ALC Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/1/2025	GEHC GE HealthCare Technologies	quarterly	$0.0350	0.19%	7/25/2025	7/25/2025	8/15/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ALC Alcon	0.21	2.70	1.66
GEHC GE HealthCare Technologies	0.73	0.98	0.76
HLN Haleon	0.53	0.98	0.78
IDXX IDEXX Laboratories	0.31	1.16	0.81

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ALC Alcon	53.86%
GEHC GE HealthCare Technologies	82.06%
HLN Haleon	6.67%
IDXX IDEXX Laboratories	87.84%

Insider Ownership

Company	Insider Ownership
ALC Alcon	N/A
GEHC GE HealthCare Technologies	0.27%
HLN Haleon	N/A
IDXX IDEXX Laboratories	0.98%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ALC Alcon	25,599	493.24 million	N/A	Optionable
GEHC GE HealthCare Technologies	53,000	457.89 million	456.65 million	Optionable
HLN Haleon	24,561	4.49 billion	N/A	Not Optionable
IDXX IDEXX Laboratories	11,000	80.42 million	79.63 million	Optionable

IDXX, HLN, GEHC, and ALC Headlines

Recent News About These Companies

IDXX IDEXX Laboratories, Inc. - Seeking Alpha

3 hours ago | seekingalpha.com

IDXX - IDEXX Laboratories Inc Dividends - Morningstar

July 8 at 1:27 PM | morningstar.comM

Ninety One SA PTY Ltd Purchases 1,551 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)

July 8 at 7:08 AM | marketbeat.com

China Universal Asset Management Co. Ltd. Boosts Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX)

July 8 at 7:07 AM | marketbeat.com

Bank of New York Mellon Corp Sells 10,462 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)

July 8 at 5:14 AM | marketbeat.com

Will Idexx (IDXX) Beat Estimates Again in Its Next Earnings Report?

July 7 at 1:11 PM | zacks.com

IDEXX Laboratories (NASDAQ:IDXX) Hits New 12-Month High - Should You Buy?

July 7 at 12:20 PM | marketbeat.com

IFM Investors Pty Ltd Boosts Stock Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX)

July 6 at 5:47 AM | marketbeat.com

DAVENPORT & Co LLC Boosts Stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX)

July 5 at 4:46 AM | marketbeat.com

Kintegral Advisory LLC Sells 1,814 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)

July 4, 2025 | marketbeat.com

Teacher Retirement System of Texas Buys 37,163 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)

July 4, 2025 | marketbeat.com

Stifel Nicolaus Issues Positive Forecast for IDEXX Laboratories (NASDAQ:IDXX) Stock Price

July 4, 2025 | americanbankingnews.com

IDXX Stock Price Quote | Morningstar

July 3, 2025 | morningstar.comM

Principal Financial Group Inc. Grows Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX)

July 3, 2025 | marketbeat.com

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Stake Raised by Tandem Investment Advisors Inc.

July 3, 2025 | marketbeat.com

Novem Group Acquires 681 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)

July 3, 2025 | marketbeat.com

IDEXX Laboratories (NASDAQ:IDXX) Price Target Raised to $540.00 at Stifel Nicolaus

July 2, 2025 | marketbeat.com

Wilson Asset Management International PTY Ltd. Takes Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX)

July 2, 2025 | marketbeat.com

Sumitomo Mitsui DS Asset Management Company Ltd Purchases 605 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)

July 2, 2025 | marketbeat.com

New York State Teachers Retirement System Has $28.36 Million Stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX)

July 2, 2025 | marketbeat.com

Cambridge Investment Research Advisors Inc. Lowers Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX)

July 2, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

IDXX, HLN, GEHC, and ALC Company Descriptions

Alcon NYSE:ALC

$87.00 +0.20 (+0.23%)

Closing price 03:59 PM Eastern

Extended Trading

$85.00 -2.00 (-2.29%)

As of 07:33 PM Eastern

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

GE HealthCare Technologies NASDAQ:GEHC

$75.20 +0.59 (+0.79%)

Closing price 04:00 PM Eastern

Extended Trading

$75.72 +0.52 (+0.69%)

As of 07:49 PM Eastern

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. It has an AI collaboration with Mass General Brigham. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

Haleon NYSE:HLN

$10.04 -0.11 (-1.08%)

Closing price 03:59 PM Eastern

Extended Trading

$10.03 -0.01 (-0.10%)

As of 07:59 PM Eastern

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

IDEXX Laboratories NASDAQ:IDXX

$538.84 -6.72 (-1.23%)

Closing price 04:00 PM Eastern

Extended Trading

$537.99 -0.85 (-0.16%)

As of 07:58 PM Eastern

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time